The constitutive production of the endocannabinoid 2‐arachidonoylglycerol participates in oligodendrocyte differentiation
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Endocannabinoids have recently emerged as instructive cues in the developing central nervous system, and, based on the expression of their receptors, we identified oligodendrocytes as potential targets of these molecules. Here, we show that the enzymes responsible for the synthesis of the endocannabinoid 2‐arachidonoylglycerol (2‐AG), diacylglycerol lipase alpha (DAGLα) and beta (DAGLβ), and degradation, monoacylglycerol lipase (MAGL), can be found in oligodendrocytes at different developmental stages. Moreover, cultured oligodendrocyte progenitor cells (OPCs) express DAGLα and β abundantly, resulting in the stronger production of 2‐AG than in differentiated oligodendrocytes. The opposite is observed with MAGL. CB1 and CB2 receptor antagonists (SR141716 and AM630) impaired OPC differentiation into mature oligodendrocytes and likewise, inhibiting DAGL activity with RHC‐80267 or tetrahydrolipstatin also blocked oligodendrocyte maturation, an effect reversed by the addition of exogenous 2‐AG. Likewise, 2‐AG synthesis disruption using specific siRNAs against DAGLα and DAGLβ significantly reduced myelin protein expression in vitro, whereas a pharmacological gain‐of‐function approach by using cannabinoid agonists or MAGL inhibition had the opposite effects. ERK/MAPK pathway is implicated in oligodendrocyte differentiation because PD98059, an inhibitor of MEK1, abrogated oligodendrocyte maturation. The cannabinoid receptor antagonists and RHC‐80267 all diminished basal ERK1/2 phosphorylation, effects that were partially reversed by the addition of 2‐AG. Overall, our data suggest a novel role of endocannabinoids in oligodendrocyte differentiation such that constitutive release of 2‐AG activates cannabinoid receptors in an autocrine/paracrine way in OPCs, stimulating the ERK/MAPK signaling pathway. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 2×
“Thewell-characterized arachidonic acid derivatives,Narachidonoylethanolamine (anandamide [AEA]) and 2arachidonoylglycerol (2-AG) are the main endogenous ligands for the CB1 and CB2 cannabinoid receptors (Devane et al., 1992; Mechoulam et al., 1995; Sugiura et al., 1995).”
BackgroundThe Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 3×
“…are abundantly expressed in developing and adult brain, in regions involved in the control of motor coordination, memory, and cognitive processes (Herkenham et al., 1991; Mailleux and Vanderhaeghen 1992), whereas CB2 receptors seems to be restricted in the brain to microglial cells (for a review…”
BackgroundInfluentialThe molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 2×
“Endocannabinoids are not stored in intracellular compartments but produced on demand from membrane lipid precursors in an activity-dependent manner (Piomelli, 2003).”
BackgroundIdentification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“To determine whether these cells have the complete molecular machinery for 2-AG metabolism, we also studied the expression of MAGL, mainly responsible of 2-AG hydrolysis in the brain (Blankman et al., 2007; Dinh et al., 2002).”
BackgroundCell death and control of cell survival in the oligodendrocyte lineage
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345 · cited 2×
“The nonadherent OPCs that remained in suspension were recovered and further purified by immunopanning (Barres et al., 1992).”
MethodA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177 · cited 1×
“To determine whether these cells have the complete molecular machinery for 2-AG metabolism, we also studied the expression of MAGL, mainly responsible of 2-AG hydrolysis in the brain (Blankman et al., 2007; Dinh et al., 2002).”
BackgroundBisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039 · cited 8×
“%) after 2-AG administration (P < 0.05 vs. THL; n 5 3).”
BackgroundInfluential
Cited by
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
Galve-Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 283
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
Mecha, M., Feliú, A., Carrillo-Salinas, F. J., Rueda-Zubiaurre, A., Ortega-Gutiérrez, S., de Sola, R. G., & Guaza, C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.002 · Cited by 234
Self-citationEndocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling
Alpár, A., Tortoriello, G., Calvigioni, D., Niphakis, M. J., Milenkovic, I., Bakker, J., Cameron, G. A., Hanics, J., Morris, C. V., Fuzik, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5421 · Cited by 96
Metadata
- Authors
- Gomez, O., Arevalo‐Martin, A., Garcia‐Ovejero, D., Ortega‐Gutierrez, S., Cisneros, J. A., Almazan, G., Sánchez‐Rodriguez, M. A., Molina‐Holgado, F., & Molina‐Holgado, E.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2010-09-27
- Volume
- 58
- Issue
- 16
- Pages
- 1913-1927
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2021799361
- Cited by
- 89
- References
- 15
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The constitutive production of the endocannabinoid 2‐arachidonoylglycerol participates in oligodendrocyte differentiation. https://app.cochat.ai/papers/10.1002/glia.21061
- The paper
- Gomez, O., Arevalo‐Martin, A., Garcia‐Ovejero, D., Ortega‐Gutierrez, S., Cisneros, J. A., Almazan, G., Sánchez‐Rodriguez, M. A., Molina‐Holgado, F., & Molina‐Holgado, E. (2010). The constitutive production of the endocannabinoid 2‐arachidonoylglycerol participates in oligodendrocyte differentiation. Glia. https://doi.org/10.1002/glia.21061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.